Setrusumab receives Breakthrough Therapy designation from the FDA Cash of $80.5 million as of September 30, 2024, expected to fund operations into 2027 LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ...
KDEV) today announces that its portfolio company BOOST Pharma has succesfully completed a pre-IND meeting with the U.S. Food and Drug Administration, FDA, for its cell therapy aiming to treat children ...
Ten-year-old Adam King launched his first book, called Farron’s Adventure, at The Book Centre in Waterford City on Saturday ahead of the 12th annual Winterval Festival. All proceeds from the sale of ...